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Inflammatory responses at mucosal surfaces after human im-
munodeficiency virus type 1 (HIV-1) transmission may influ-
ence disease outcome. We evaluated levels of interleukin (IL)–
1, IL-6, tumor necrosis factor–, IL-8, IL-10, and IL-12 in
genital tract and plasma specimens from 44 women with acute
HIV infection and 29 HIV-negative control women (13 of
whom were women in the acute HIV infection cohort who had
preinfection samples available for analysis). Women with
acute HIV infection had significantly elevated levels of IL-6,
IL-10, and IL-12 in genital tract specimens and elevated levels
of IL-1, IL-8, and IL-10 in plasma specimens, compared with
HIV-negative control women. Levels of IL-1, IL-6, and IL-8
in cervicovaginal specimens from women with acute HIV in-
fection showed a significant inverse correlation with systemic
CD4 cell counts, suggesting that mucosal inflammation is as-
sociated with low CD4 cell counts during acute HIV
infection.
The majority of the world’s human immunodeficiency virus
type 1 (HIV-1) infections now occur in women. Immune re-
sponses in the female genital tract during the acute phase of HIV
infection may be an important determinant of both early control
of viral replication and long-term progression of disease [1].
Despite the fact that, during sexual transmission, a woman’s ini-
tial exposure to HIV-1 occurs at mucosal surfaces in the genital
tract, little is known about HIV-1–specific immune responses at
this site early after infection [2]. Importantly, rapid and exten-
sive depletion of mucosal and systemic CD4 T cells occurs dur-
ing the first few weeks of infection [1]. Evidence from both HIV
and simian immunodeficiency virus (SIV) infections suggests a
more substantial impact of the virus on the mucosal immune
system than its systemic counterpart [1]. Because equilibrium
between viral replication, immune control, and CD4 T cell de-
pletion is set early during HIV infection, information on the
composition, timing, and duration of early mucosal cytokine
responses, especially at the site of virus entry and initial replica-
tion, could substantially contribute to understanding the immu-
nopathology of AIDS [3].
Recent studies involving nonhuman primates have shown
that SIV establishes infection systemically before robust adaptive
immune responses are detected in blood, indicating that early
innate immune responses may therefore be important in pre-
venting widespread dissemination of virus [4]. In many viral
illnesses, a robust immune response is crucial for effective con-
trol of virus replication and spread. In HIV and SIV infections,
however, certain responses may have very undesirable out-
comes. In macaques, for example, the earliest cytokine responses
during SIV infection favor immune activation, which facilitates
rather than controls viral replication and spread by recruiting
the virus’ target cells to the sites of viral replication [3]. Multiple
studies of both HIV and SIV infection show a correlation be-
tween increased degrees of T cell activation and increased rates
of disease progression [5–7].
In this study, we report on levels of inflammatory cytokines in
a cohort of woman both before HIV acquisition and during the
acute phase of HIV infection. We measured levels of cytokines in
genital tract secretions (obtained via cervicovaginal lavage
[CVL]) and plasma samples at these 2 time points and compared
them with levels in samples from a control group of HIV-
uninfected women. The relationship between genital tract and
plasma levels of inflammatory cytokines during acute infection
and clinical markers of disease progression (i.e., systemic CD4
cell counts and virus loads) are examined.
Subjects and methods. Forty-four women with heterosex-
ually acquired HIV-1 infection were recruited 3 months after
infection from a longitudinal HIV-negative cohort into the CA-
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PRISA 002 Acute Infection Study in Durban, South Africa. All 44
women had tested negative for HIV antibody during their pre-
vious monthly visit. The estimated date of HIV infection was
calculated as the midpoint between the last negative result and
the first positive result of HIV antibody tests; or as 14 days where
the women were HIV RNA positive and HIV antibody negative.
CVL and plasma samples were obtained from all 44 women.
Two groups of control CVL and plasma specimens were cre-
ated. The first group consisted of samples obtained before HIV
infection from 13 of the 44 women from the acute HIV infection
cohort. The second control group consisted of samples from 16
women in the longitudinal HIV-negative cohort who had not
become infected during follow-up. These 16 women were
matched to the 44 women with acute HIV infection on the basis
of age, hormone contraception use, and prevalence of sexually
transmitted infections (STIs).
Cervical swabs and blood specimens were tested for Chla-
mydia trachomatis, Neisseria gonorrhea, Mycoplasma genitalium,
agents of bacterial vaginosis, herpes simplex virus type 2 (HSV-
2), Trichomonas vaginalis, and Treponema pallidum. C. tracho-
matis, N. gonorrhea, and M. genitalium were assessed by poly-
merase chain reaction (PCR), agents of bacterial vaginosis by
Gram stain, HSV-2 by a combination of IgG serological tests and
PCR of vulvovaginal swab specimens, T. vaginalis by Diamond’s
culture and PCR, and T. pallidum by a combination of the Im-
muntrepTPHA test, the Macro-Vue RPR Card test, and PCR.
Gynecologic examination was performed with collection of
CVL specimens on enrollment. The cervix was bathed with ster-
ile saline (10 mL), which was allowed to pool in the posterior
fornix, where it was then aspirated into a plastic bulb pipette.
Fluid was dispensed into a sterile container and centrifuged, and
the supernatant was stored at 80°C. Collection of the CVL
sample was postponed until the following week if the participant
was menstruating. None of the CVL samples had visible blood
contamination. Blood collection was performed by venipunc-
ture into acetate citrate dextran vacutainer tubes. Plasma was
stored at 80°C.
We investigated the effect of acute HIV infection on the in-
flammatory cytokine milieu at the genital mucosa and compared
this to systemic inflammation at the same time point. The hu-
man inflammation cytometric bead array system (BD Biosci-
ences) was used to measure the concentrations of interleukin
(IL)–1, IL-6, tumor necrosis factor (TNF)–, IL-8, IL-10, and
IL-12 p70 in CVL and plasma specimens. The upper limit of
detection for the assay was 5000 pg/mL for all cytokines. The
lower limits of detection were 3.6 pg/mL for IL-8, 7.2 pg/mL for
IL-1, 2.5 pg/mL for IL-6, 3.3 pg/mL for IL-10, 3.7 pg/mL for
TNF-, and 1.9 pg/mL for IL-12. Samples with cytokine levels
that were less than the assay’s lower limit of detection were as-
signed values that were halfway between the lower limit of de-
tection and zero.
The Mann-Whitney U test was used for independent sample
comparisons, and the Spearman rank correlation test was used
to determine covariance between variables. P values of .05
were considered statistically significant.
This study was approved by ethics committees at the Univer-
sity of KwaZulu-Natal and the University of Cape Town, and all
participants provided informed consent.
Results. A total of 44 women who had recently become in-
fected with HIV-1 by heterosexual contact were included in this
study. HIV infection for all women was in the acute phase, with
samples collected a median of 44 days (range, 15– 89 days) after
infection onset. At this time, the participants had a mean CD4
cell count of 547 cells/L (range, 201–1124 cells/L) and a mean
virus load of 319,131 copies/mL (range, 547–5,510,000 copies/
mL). Two women were pregnant at the time of infection. We
found no significant differences between inflammatory cytokine
profiles in their CVL and plasma specimens and profiles in spec-
imens from the 42 HIV-positive women who were not pregnant
(data not shown).
Levels of IL-1, IL-6, TNF-, IL-8, IL-10, and IL-12 p70 in
CVL and plasma samples obtained from women with acute HIV
infection were compared with levels in samples from HIV-
negative control specimens (figure 1). Thirteen of the control
specimens were from women in the acute HIV infection cohort
for whom preinfection samples were available, whereas 16 of the
HIV-negative control samples were from HIV-negative women
from the longitudinal HIV-negative cohort. Because inflamma-
tory cytokine levels in the 13 specimens obtained before HIV
acquisition did not differ from levels in specimens from the 16
women in the HIV-negative cohort (data not shown), data from
all HIV-negative control samples are grouped in all analyses.
Concentrations of IL-6 (P  .04), IL-10 (P  .004), and IL-12
p70 (P  .04) in CVL samples from women with acute HIV
infection were significantly greater than those in HIV-negative
CVL samples. Although inflammatory cytokine levels in plasma
specimens were significantly lower than those in CVL specimens
(P  .001), we observed a significant increase in levels of several
inflammatory cytokines in plasma from women with acute HIV
infection, compared with levels in HIV-negative plasma samples
(P  .004 for IL-1, P  .0001 for IL-8, and P  .0002 for
IL-10).
To investigate the impact of concurrent STI and bacterial
vaginosis on cytokine responses during acute HIV infection, we
compared inflammatory cytokine levels in women without con-
comitant STI or bacterial vaginosis with levels in women with
concomitant bacterial vaginosis or 1 STI. Twenty-one (47.7%)
of 44 women with acute HIV infection were coinfected with 1
STI, whereas 34 (77.3%) of 44 had bacterial vaginosis during the
acute phase of HIV infection. In the genital tract, levels of IL-12,
IL-8, TNF-, IL-10, and IL-1 did not differ significantly be-
tween women with no STIs and those with 1 STI. Levels of IL-6
in CVL specimens, however, were significantly elevated in
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Figure 1. Comparison of inflammatory cytokine concentrations in cervicovaginal lavage (A) and plasma (B) samples from 44 women with acute HIV
infection (acute HIV) and 29 women without HIV infection (HIV neg; see “Subjects and methods” for a description of the HIV-negative group). Values
below the lower limit of detection of the assay are reported as the midpoint between lower limit of detection and zero. Differences between groups
were calculated using Mann-Whitney U test. P values of .05 were considered significant. Dots, cytokine levels for each study subject; horizontal lines,
median values for each group.
women coinfected with 1 STI, compared with women with
HIV infection only (P  .006). In plasma, the presence of 1
concomitant STI had no effect on inflammatory cytokine levels
during acute HIV infection (data not shown). In women with
concomitant bacterial vaginosis, we similarly found that IL-12,
IL-8, TNF-, IL-10, and IL-1 levels in CVL and plasma samples
did not change significantly (data not shown). IL-6 levels in CVL
specimens from women with acute HIV infection and bacterial
vaginosis, however, were 7-fold higher than those for women
with acute HIV infection and no bacterial vaginosis or STI
(P  .02). Because bacterial vaginosis, 1 concomitant STI,
and acute HIV-1 infection all resulted in significantly elevated
IL-6 levels in CVL (figure 1), the contribution of each agent in
driving production of this cytokine is not clear.
Finally, we evaluated the impact of inflammatory cytokine
production and clinical indicators of HIV disease progression
(i.e., virus load and systemic CD4 cell count during acute HIV
infection). We observed no association between levels of inflam-
matory cytokines in either plasma specimens (data not shown)
or CVL specimens (figure 2) and viremia in women during acute
HIV-1 infection. However, when genital tract inflammation and
CD4 cell counts were compared, we observed a significant in-
verse correlation between systemic CD4 cell counts and IL-1
levels (r  -0.35; P  .02), IL-6 levels (r  -0.32; P  .05),
and IL-8 levels (r  -0.32; P  .04), indicating that enhanced
inflammation at the cervix is associated with more-severe CD4
T cell depletion during these early time points (figure 2).
Discussion. Cytokine profiles and mucosal inflammation in
the genital tract during acute HIV infection are associated with
lower CD4 cell counts and may thereby impact disease progres-
sion. We found that elevated levels of IL-1 , IL-6, and IL-8 in
the genital tract correlated with lower systemic CD4 cell counts
during acute HIV infection. It would be interesting to evaluate
whether genital inflammation was similarly associated with the
extent of CD4 cell destruction in the mucosa; however, muco-
sal CD4 cell depletion was not measured in this study.
We found that levels of IL-10, IL-6, and IL-12 inflammatory
cytokines in the genital compartments of women with acute HIV
infection were significantly higher than those for HIV-negative
women. Although IL-10 levels were also significantly increased
in plasma samples from HIV-positive women, so too were IL-8
and IL-1 levels.
Recent research has shown that, during acute infection, HIV
pathogenesis is focused in the gut and gastrointestinal-
associated lymphoid tissue (GALT), where CD4 T cells become
massively depleted [8 –10] and inflammatory cytokines and che-
mokines are upregulated [11]. Studies of virus-host interactions
in the gut have demonstrated that immune activation is emerg-
ing as a potentially important factor in the destruction of host
CD4 T cells in the GALT. We show here that local genital tract
inflammation is associated with systemic CD4 T cell depletion.
Figure 2. Comparison of inflammatory cytokine concentrations,
plasma virus load, and systemic CD4 cell counts in cervicovaginal
lavage samples from 44 women with acute HIV infection. Dots, individ-
uals’ virus loads and CD4 cell counts, by cytokine level. Values below
the lower limit of detection of the assay are reported as the midpoint
between lower limit of detection and zero. Correlations were calculated
using the Spearman rank correlation test. P values of .05 were con-
sidered significant. Dots, virus loads and CD4 cell counts, by cytokine
level, for each study subject; solid line, linear regression for each
comparison and the r and P values.
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We anticipate that inflammation of the female genital tract may
similarly undermine effective control of HIV after transmission.
Several studies have shown that bacterial vaginosis and certain
STIs increase secretion of cervical inflammatory mediators both
in the absence and the presence of HIV infection [12, 13]. Fur-
thermore, STIs increase susceptibility to HIV infection and HIV
shedding in HIV-infected individuals [12–14]. Our data show
that acute HIV infection is associated with elevated cytokine lev-
els regardless of the concomitant presence of STIs. The presence
of bacterial vaginosis or STIs at the first visit following HIV ac-
quisition had little or no impact in the genital tract on all cyto-
kines assessed, apart from IL-6.
We have shown here that increased genital inflammation is an
important feature of acute HIV infection and that this local in-
flammation is significantly associated with lower systemic CD4
cell counts. It would be of interest to determine whether these
genital and systemic cytokine profiles during acute HIV infec-
tion influence local proliferation of HIV in the genital tract and,
in turn, systemic viral replication and disease progression.
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